Drug Discount Monitor

February 2009 Headlines

Drug Maker Sued Over Prices Also Skirting 340B Rules?

FTC sued Ovation over price gouging. But is the drug maker also ignoring 340B rules? The Monitor investigates Ovation’s pricing policies. Read more

CBO: Higher Medicaid Rebates May Lower Deficit By $7.2 Billion

The Congressional Budget Office is tackling the national deficit with proposals that would benefit 340B and Medicaid. But manufacturers balk at the idea of raising rebates. Read more

Off-Label Marketing Litigation Boon For 340B Providers

340B providers get yet another slice of a huge off-label marketing settlement. This time, Eli Lilly is writing the refund checks. Read more

The Waiting Game Continues for Children’s Hospitals

Children’s hospitals have been left out in the cold for nearly three years. When will the feds implement legislation that gave them 340B status? Read more

CMS Tweaks Medicare Part D for Patients and Plans

CMS is tweaking Medicare Part D for patients and plans. The government wants lower costs and improved access for beneficiaries of the large drug discount program. Read more